BDTX — Black Diamond Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSuper Stock

Annual balance sheet for Black Diamond Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	315	210	123	131	98.6
Prepaid Expenses
Total Current Assets	320	216	128	134	101
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	8.79	30.7	27.4	23.7	20.4
Other Long Term Assets
Total Assets	330	248	156	159	123
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	14.2	23.6	15.3	19.6	20.6
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	21.9	51.8	40.6	41.8	39.4
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	308	196	116	117	83.3
Total Liabilities & Shareholders' Equity	330	248	156	159	123
Total Common Shares Outstanding